We are live on
!
Find out more
LBC
Lawrence B. Cohen Portfolio holdings
AUM
$2.06M
1-Year Est. Return
34.47%
This Fund
S&P 500
This Quarter
Est. Return
-6.6%
1 Year Est. Return
+34.47%
3 Year Est. Return
+41.85%
5 Year Est. Return
+126.65%
10 Year Est. Return
+272.7%
AUM
$144M
AUM Growth
-$14.6M
(-9.2%)
Cap. Flow
-$3.16M
Cap. Flow
% of AUM
-2.2%
Top 10 Holdings %
Top 10 Hldgs %
45.23%
Holding
70
New
2
Increased
19
Reduced
36
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.07M |
| 2 |
Johnson & Johnson
JNJ
|
+$846K |
| 3 |
Humana
HUM
|
+$622K |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$489K |
| 5 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$291K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.63M |
| 2 |
Gilead Sciences
GILD
|
+$1.75M |
| 3 |
Baxter International
BAX
|
+$268K |
| 4 |
Merck
MRK
|
+$255K |
| 5 |
Comcast
CMCSA
|
+$201K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.1% |
| 2 | Technology | 20.59% |
| 3 | Consumer Staples | 11.12% |
| 4 | Energy | 8.88% |
| 5 | Financials | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $12.5M | 8.7% |
65,231
+5,285
| +9% | +$1.07M |
|
2
Edwards Lifesciences
EW
$50B
| $7.47M | 5.2% |
315,288
-4,950
| -2% | -$119K |
|
3
Intel
INTC
$460B
| $7.17M | 4.99% |
238,058
-575
| -0.2% | -$16.6K |
|
4
PepsiCo
PEP
$191B
| $6.78M | 4.72% |
71,889
-670
| -0.9% | -$63.7K |
|
5
TJX Companies
TJX
$176B
| $6.24M | 4.34% |
174,680
+420
| +0.2% | +$14.7K |
|
6
Stryker
SYK
$133B
| $6.01M | 4.18% |
63,893
-800
| -1% | -$79.3K |
|
7
Medtronic
MDT
$110B
| $4.9M | 3.41% |
73,234
-651
| -0.9% | -$47.9K |
|
8
Microsoft
MSFT
$3.35T
| $4.68M | 3.26% |
105,760
+535
| +0.5% | +$24K |
|
|
9
Apple
AAPL
$4.9T
| $4.64M | 3.23% |
168,352
-123,652
| -42% | -$3.63M |
|
10
CVS Health
CVS
$134B
| $4.6M | 3.2% |
47,645
+245
| +0.5% | +$25.8K |
|
11
Procter & Gamble
PG
$335B
| $4.43M | 3.09% |
61,621
-100
| -0.2% | -$7.5K |
|
|
BHI
12
DELISTED
Baker Hughes
BHI
| $4.42M | 3.07% |
84,879
-3,275
| -4% | -$183K |
|
13
iShares MSCI EAFE ETF
EFA
$78.5B
| $4.21M | 2.93% |
73,525
-275
| -0.4% | -$17K |
|
14
3M
MMM
$90.8B
| $4.06M | 2.83% |
34,265
-240
| -0.7% | -$29.5K |
|
15
US Bancorp
USB
$98B
| $3.98M | 2.77% |
96,953
+325
| +0.3% | +$14.1K |
|
|
RDS.B
16
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $3.9M | 2.72% |
82,237
-325
| -0.4% | -$17.5K |
|
17
Abbott
ABT
$183B
| $3.77M | 2.62% |
93,649
-650
| -0.7% | -$30.6K |
|
|
18
Johnson & Johnson
JNJ
$617B
| $3.67M | 2.56% |
39,359
+8,743
| +29% | +$846K |
|
19
Cognizant
CTSH
$24.3B
| $3.23M | 2.25% |
51,535
+250
| +0.5% | +$15.7K |
|
20
Qualcomm
QCOM
$159B
| $3.08M | 2.14% |
57,231
-585
| -1% | -$34.8K |
|
21
Corning
GLW
$116B
| $3.03M | 2.11% |
177,069
-1,500
| -0.8% | -$27K |
|
22
ExxonMobil
XOM
$651B
| $2.96M | 2.06% |
39,860
+463
| +1% | +$35.7K |
|
23
Applied Materials
AMAT
$398B
| $2.59M | 1.8% |
176,238
-1,000
| -0.6% | -$16.7K |
|
24
Emerson Electric
EMR
$83.3B
| $2.2M | 1.53% |
49,875
+175
| +0.4% | +$8.61K |
|
|
25
Gilead Sciences
GILD
$163B
| $2.2M | 1.53% |
22,434
-15,751
| -41% | -$1.75M |
|
Similar funds
ICM
TA
SCM
LCMP
GIP
STC
GC
DU
Lawrence B. Cohen's Q3 2015 Portfolio in Review
As of Q3 2015, Lawrence B. Cohen held 70 positions worth $144M, down 9.2% from $158M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Lawrence B. Cohen's Q3 2015 filing shows 2 new, 19 increased, 36 reduced and 2 closed positions. Its largest new stake was Humana: 3,366 shares worth $603K. The largest sale was Apple, an estimated $3.63M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
- Lawrence B. Cohen's largest Q3 2015 buy was Humana: 3,366 shares worth $603K.
- Lawrence B. Cohen added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $1.07M increase.
- Lawrence B. Cohen's biggest Q3 2015 reduction was Apple, cutting an estimated $3.63M.
- Lawrence B. Cohen fully exited Merck in Q3 2015, selling an estimated $255K.
- Lawrence B. Cohen's ten largest holdings make up 45% of its $144M portfolio in Q3 2015.
- Lawrence B. Cohen opened 2 new positions and closed 2 in Q3 2015.
- Lawrence B. Cohen's portfolio value fell 9.2% quarter-over-quarter to $144M.
Based on Lawrence B. Cohen's 13F filing for Q3 2015, filed 6 Oct 2015.